[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.] Basinski H, Jensen H B, Stenager E Ugeskr Laeger. 2014 Mar 17; 176(12A). PMID: 25350886. Abstract CommentRecommendBookmarkWatch